In the present study, we demonstrated that patients with RA have upregulated percentages of circulating CD4+ T, CD19+ B, Th17, ILC2s, and ILC3s and downregulated percentages of Treg and ILC1s. This evidence concerns the gene CD4 and rheumatoid arthritis.